Abstract
The European vascular access market examines both mature and developing device
markets. The ongoing adoption of next-generation devices, including
power-injectable and antimicrobial-coated devices, will contribute to changing
market dynamics in both mature and developing device segments. The growing use
of these new technologies will create novel areas for significant market
expansion
|